Annovis Bio, Inc. — Form 8-K
Filed November 4, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 15/100
What the filing says
An 8-K was filed by Annovis Bio on November 4, 2026, citing Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 8.01 (Other Events). The filing document text itself was not provided in the submission—only structural metadata (XBRL taxonomy files, accession numbers, and company identifiers) appears in the supplied text. Specific financial results, operational changes, or material events cannot be identified without access to the actual 8-K narrative.
Why this rating
Filing metadata only; substantive disclosure absent. Cannot assess materiality to $36.1M market-cap company without actual event details.
Extracted items
- 2.02 results / earnings
- 7.01 Reg FD disclosure
- 8.01 other event
See more from November 4, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.